GAPVD1 siRNA (Human)
SiRNA to inhibit GAPVD1 expression using RNA interference
Product Specifications
Product Name Alternative
GAPEX5; KIAA1521; RAP6; GTPase-activating protein and VPS9 domain-containing protein 1; GAPex-5; Rab5-activating protein 6
Reactivity
H
Source
Synthetic
Applications
RNAi
Purity
> 97%
Form
Lyophilized powder
Components
We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human GAPVD1 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Specificity
GAPVD1 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
NCBI Gene Symbol
GAPVD1
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
SwissProt (Human)
Q14C86
Entrez GeneHuman
26130
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
D8080-04-ML750 100 µL
DOK4, CT (Docking Protein 4, Downstream Of Tyrosine Kinase 4, Insulin Receptor Substrate 5, IRS-5, IRS5) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
K4097005 3x 1.0 µg
Prl2b1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
Sign In for Pricing
View Details 